Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.

Try Elite for Free

Changes in company's own shares

By Alvotech | December 29, 2025, 2:40 PM

Attached is a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding changes in company's own shares.

Attachment

Alvotech Own Shares Notification 29 Dec 2025

Mentioned In This Article

Latest News

Oct-20	Alvotech shares jump premarket after FDA approves new Simlandi process ALVO Investing.com
Oct-20	Alvotech Receives FDA Approval for New SIMLANDI Manufacturing Process That More Than Doubles Output Per Batch ALVO GlobeNewswire
Oct-14	Alvotech and Advanz Pharma announce first known regulatory submission worldwide for proposed biosimilar to Eylea 8 mg ALVO GlobeNewswire
Oct-06	Alvotech and LOTTE Biologics announce US-based manufacturing agreement to increase global supply ALVO GlobeNewswire
Oct-05	Alvotech Soars 13% on FDA Nod That Effectively Doubles US Humira Biosimilar Capacity ALVO +12.11% TIKR
Oct-05	Alvotech stock surges after FDA manufacturing approval ALVO +12.11% Investing.com
Oct-05	FDA approves additional U.S. manufacturing capacity for SIMLANDI, Alvotech's biosimilar to Humira ALVO +12.11% GlobeNewswire
Sep-16	ALVO Stock Jumps On Double Upgrade Why Barclays Sees A 59% Upside ALVO Stocktwits
Sep-16	Alvotech Shares Rise 5.6% After Barclays Upgrades Rating and Doubles Price Target ALVO InvestorsHub
Aug-31	Alvotech Announces FDA Acceptance for Review of Biologics License Application for AVT80, Expanding Proposed Biosimilar Program for Entyvio to Subcutaneous Presentations ALVO GlobeNewswire
Aug-27	Alvotech to present at upcoming investor conferences in September ALVO GlobeNewswire
Aug-24	BofA starts bullish Alvotech coverage on biosimilar launch cycle ALVO +18.51% Investing.com
Aug-21	Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets ALVO GlobeNewswire
Aug-19	Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update ALVO ALVO +7.02% GlobeNewswire
Aug-19	Earnings To Watch: Alvotech (ALVO) Q2 2026 -- GF Value Sees 461% Upside ALVO GuruFocus.com

Affiliate • Advertise • APIs • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)